Roseville, MN, United States of America

Jing Xiao

This inventor holds 1 USPTO granted patent. Top assignee: Regents of the University of Minnesota. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Xiao. Retrieved from https://idiyas.com/inventor/jing-xiao-vgyc50fa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jing Xiao - Innovator in Stem Cell Research

Introduction

Jing Xiao is a prominent inventor based in Roseville, MN (US). She has made significant contributions to the field of stem cell research, particularly in the therapeutic applications of umbilical cord blood stem cells. Her innovative work has the potential to impact the treatment of ischemic events.

Latest Patents

Jing Xiao holds a patent for the "Use of umbilical cord blood stem cells to treat ischemic event." This invention relates to methods for the isolation and culture of umbilical cord blood stem cells, as well as the therapeutic uses for those cells. She has 1 patent to her name, showcasing her dedication to advancing medical science.

Career Highlights

Jing Xiao is affiliated with the Regents of the University of Minnesota, where she continues her research and development in stem cell therapies. Her work is recognized for its potential to revolutionize treatment options for patients suffering from ischemic conditions.

Collaborations

Jing collaborates with esteemed colleagues, including Zhenhong Nan and Walter C. Low. Their combined expertise enhances the research efforts and broadens the scope of their innovative projects.

Conclusion

Jing Xiao's contributions to stem cell research exemplify the impact of innovation in medicine. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…